Logo

Polynoma Presenting Interim Phase III Data for Its Investigati...

SAN DIEGO, Nov. 6, 2019 /PRNewswire-AsiaNet/ -- -- MAVIS Study Identifies Most Responsive Patient Subpopulations, Supporting the Continued Study of Adjuvant Treatment in Localized Melanoma Patients --Polynoma LLC ( https://c212.net/c/link/?t=0&l=en&o=2626341-1&h=999912147&u=http%3A%2F%2Fwww...

Authors: LATEST ASIANET NEWS RELEASES

Read more

Asian Spectator by NewsServices.com - office@NewsServices.com - 1300 660 660